Exscientia

Organization

AI drug discovery company, merged with Recursion Pharmaceuticals

2 stories

DeepMind CEO Demis Hassabis Pursues AI-Automated Drug Design

Anthropic Acquires Biotech Startup Coefficient Bio for Over $400 Million